News

Researchers show that the generalized immune-boosting properties of many vaccines can cross-protect patients against multiple pathogens.

A new study conducted in mice demonstrates precisely how triclosan, an antimicrobial found in toothpaste, toys and thousands of other products, can trigger gut inflammation.

Scientists have discovered an antibody that may lead to more effective treatments against a wide range of sarbecoviruses, the family of viruses that includes the coronavirus SARS-CoV-2 and their variants.

A study describes a new method for analyzing pyroptosis and shows that the process can in fact be halted and controlled.

Results of a new study represent a step toward improving our understanding of Crohn’s disease and the factors that cause its intestinal inflammation.

A new study provides the first evidence of a protective role for common cold T cells in combating SARS-CoV-2.

SARS-CoV-2 antibodies are transferred from vaccinated mothers to their babies through breastmilk.

Scientists at IST Austria have discovered how immune cells protect their sensitive insides as they squeeze between tissue cells.

Scientists studied the sensitivity of the Omicron variant to monoclonal antibodies used in clinical practice to prevent severe forms of the disease in people at risk, as well as to antibodies in the blood of individuals previously infected with SARS-CoV-2 or vaccinated.

A study shows that the majority of people with inflammatory rheumatic and musculoskeletal diseases tolerate their COVID vaccine well – with no difference in safety profile to that seen in the general population.